Wegener's granulomatosis: an update on diagnosis and therapy
Authors: Manna, R; Cadoni, G; Ferri, E; Verrecchia, E; Giovinale, M; Fonnesu, C; Calò, L; Armato, E; Paludetti, G
Source: Expert Review of Clinical Immunology, Volume 4, Number 4, July 2008 , pp. 481-495(15)
Publisher: Expert Reviews
Abstract:
Wegener's granulomatosis (WG) is a unique clinicopathological disease characterized by necrotizing granulomatous vasculitis of the respiratory tract, pauci-immune necrotizing glomerulonephritis and small-vessel vasculitis. Owing to its wide range of clinical manifestations, WG has a broad spectrum of severity that includes the potential for alveolar hemorrhage or rapidly progressive glomerulonephritis, which are immediately life threatening. WG is associated with the presence of circulating antineutrophil cytoplasm antibodies (c-ANCAs). The most widely accepted pathogenetic model suggests that c-ANCA-activated cytokine-primed neutrophils induce microvascular damage and a rapid escalation of inflammation with recruitment of mononuclear cells. The diagnosis of WG is made on the basis of typical clinical and radiologic findings, by biopsy of involved organ, the presence of c-ANCA and exclusion of all other small-vessel vasculitis. Currently, a regimen consisting of daily cyclophosphamide and corticosteroids is considered standard therapy. A number of trials have evaluated the efficacy of less-toxic immunosuppressants and antibacterials for treating patients with WG, resulting in the identification of effective alternative regimens to induce or maintain remission in certain subpopulations of patients. Recent investigation has focused on other immunomodulatory agents (e.g., TNF-α inhibitors and anti-CD20 antibodies), intravenous immunoglobulins and antithymocyte globulins for treating patients with resistant WG.Keywords: diagnosis; etiopathogenesis; therapy; update; Wegener's granulomatosis
Document Type: Research article
DOI: http://dx.doi.org/10.1586/1744666X.4.4.481
Affiliations: 1: Clinical Autoimmunity Unit, Department of Internal Medicine, Catholic University of the Sacred Heart, Largo A Gemelli, 8-00168 Rome, Italy., Email: rmanna@rm.unicatt.it
Publication date: 2008-07-01
- Expert Review of Clinical Immunology provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in disease states with a strong immunologic component, such as allergic asthma, rheumatoid arthritis, inflammatory bowel disease, psoriasis and multiple sclerosis
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Information for Librarians
- Free Trials
- ingentaconnect is not responsible for the content or availability of external websites
- In this: publication
- By this: publisher
- In this Subject: Allergy & Immunology
- By this author: Manna, R ; Cadoni, G ; Ferri, E ; Verrecchia, E ; Giovinale, M ; Fonnesu, C ; Calò, L ; Armato, E ; Paludetti, G

Shopping cart
Receive new issue alert
Get Permissions